Attorneys Discuss Court’s Dismissal of Bad Faith Claims in In re Chelsea Therapeutics International Ltd Stockholders Litigation

In The News
October 6, 2016

Business & securities litigation partner David Hennes (New York) and private equity associate Marc Migliazzo (Boston) co-authored an article that examines the Delaware Court of Chancery’s decision to dismiss stockholder litigation alleging Chelsea Therapeutics International Ltd.’s board acted in bad faith. The article was published in the International Law Office Corporate Finance/M&A Newsletter on Oct. 5.